反应详情

Was prepared in the same manner as described in General Procedure Example 2 using 5,8-dimethyl-2-(2-(3-(pyrrolidin-1-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)vinyl)-[1,2,4]triazolo[1,5-a]pyrazine (20 mg, 51.0 μmol, Eq: 1.00) as starting material. The crude material was applied on a 5 g silicagel column using ethyl acetate/methanol 0-10% as eluent affording 5,8-dimethyl-2-{2-[5-pyrrolidin-1-yl-2-(2,2,2-trifluoro-ethyl)-2H-[1,2,4]triazol-3-yl]-ethyl}-[1,2,4]triazolo[1,5-a]pyrazine (11 mg/52.4%) as a white solid. MS: m/e=395.8 (M+H+)

1. customWas prepared in the same manner